APA

Junker R., Heinrich J., Schulte H., Tataru M., Köhler E., Schönfeld R., Nowak-Göttl U. & Assmann G. (19990303). Plasminogen activator inhibitor-1 4G/5G-polymorphism and factor V Q506 mutation are not associated with myocardial infarction in young men. : Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Chicago

Junker R, Heinrich J, Schulte H, Tataru M, Köhler E, Schönfeld R, Nowak-Göttl U and Assmann G. 19990303. Plasminogen activator inhibitor-1 4G/5G-polymorphism and factor V Q506 mutation are not associated with myocardial infarction in young men. : Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Harvard

Junker R., Heinrich J., Schulte H., Tataru M., Köhler E., Schönfeld R., Nowak-Göttl U. and Assmann G. (19990303). Plasminogen activator inhibitor-1 4G/5G-polymorphism and factor V Q506 mutation are not associated with myocardial infarction in young men. : Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

MLA

Junker R, Heinrich J, Schulte H, Tataru M, Köhler E, Schönfeld R, Nowak-Göttl U and Assmann G. Plasminogen activator inhibitor-1 4G/5G-polymorphism and factor V Q506 mutation are not associated with myocardial infarction in young men. : Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. 19990303.